Pedro Lichtinger - CEO @ Starton Therapeutics

Start Free Trial

Pricing

Overview

Number of Portfolio Companies

Number of Exits

Unlock for free

Primary Job Title CEO
Primary Organization
Starton Therapeutics

Location North Miami Beach, Florida, United States
Regions Greater Miami Area, East Coast, Southern US
Gender Male

Investor Type
obfuscated
obfuscation
Investor Stage
obfuscated
obfuscation
Number of Exits
obfuscated
obfuscation

Facebook View on Facebook
LinkedIn View on LinkedIn
X (Twitter) View on X

Pedro Lichtinger is based out of North Miami Beach, Florida, and is the CEO and Chairman of Starton Therapeutics. Pedro previously worked at Asterias Biotherapeutics as a President and CEO. Pedro Lichtinger attended Wharton School of the University of Pennsylvania.

Personal Investments

Number of Investments

Pedro Lichtinger

invested in

Asterias Biotherapeutics

obfuscation

. This investment -

Series B - Asterias Biotherapeutics

- was valued at

obfuscation

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Asterias Biotherapeutics	Yes	Series B - Asterias Biotherapeutics	obfuscated obfuscation

Exits

Number of Exits

Unlock for free

Pedro Lichtinger

has

obfuscation

exit -

Asterias Biotherapeutics

Pedro Lichtinger

has

obfuscation

exits. Their most notable exits are

Asterias Biotherapeutics

Asterias Biotherapeutics Asterias Biotherapeutics is a development-stage biotechnology company pioneering the field of regenerative medicine.

Jobs

Number of Current Jobs

Number of Past Jobs

Pedro Lichtinger

is the

CEO

Starton Therapeutics

. Additionally,

Pedro Lichtinger

has had

past jobs including

President and CEO

Asterias Biotherapeutics

Starton Therapeutics CEOMar 2017

Organization Name	Title At Company	Start Date	End Date
Asterias Biotherapeutics	President and CEO	Jun 2014	Feb 2016
Asterias Biotherapeutics	President & CEO	Jun 2014	Feb 2016
Optimer Pharmaceuticals	President & CEO	May 2010	Feb 2013
Pfizer	President Global Primary Care Business Unit	2008	2009
Pfizer	President Europe Pharmacceuticals	2006	2008
Pfizer	President Global Animal Health Business	1999	2006
Pfizer	President Europe Animal Health	1997	1999

Board and Advisor Roles

Number of Current Board & Advisor Roles

Pedro Lichtinger

holds

board and advisor roles as

Chairman

Starton Therapeutics

and

Board of Directors

Lineage Cell Therapeutics

Starton Therapeutics ChairmanMar 2017
Lineage Cell Therapeutics Board of Directors

Related Hubs

Hub Name	CB Rank (Hub)
Renmin University of China Alumni Founded Companies	78,049
University of New England Alumni Founded Companies	83,669
SDA Bocconi Alumni Founded Companies	64,841
Harvard Medical School Alumni Founded Companies	45,235
Institute of Management Technology, Ghaziabad Alumni Founded Companies	62,696
Memorial University of Newfoundland Alumni Founded Companies	69,101
Champlain College Alumni Founded Companies	64,228
Osaka University Alumni Founded Companies	81,761
American University Washington College of Law Alumni Founded Companies	88,382
University of Illinois Chicago Alumni Founded Companies	53,968